Brian Lockhart

3.5k total citations
51 papers, 2.0k citations indexed

About

Brian Lockhart is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Brian Lockhart has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in Brian Lockhart's work include Neuroscience and Neuropharmacology Research (10 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Alzheimer's disease research and treatments (5 papers). Brian Lockhart is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Alzheimer's disease research and treatments (5 papers). Brian Lockhart collaborates with scholars based in France, Austria and United States. Brian Lockhart's co-authors include Tangui Maurice, Alain Privat, Martine Largeron, Pierre Lestage, Claude Bénicourt, H. Tsiang, Pierre Renard, Maurice‐Bernard Fleury, Bruno Pfeiffer and Gilbert Dorey and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Brian Lockhart

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Lockhart France 24 956 518 450 380 352 51 2.0k
Yuemang Yao United States 25 694 0.7× 982 1.9× 372 0.8× 527 1.4× 273 0.8× 37 2.3k
Christophe Furman France 28 1.9k 2.0× 432 0.8× 445 1.0× 229 0.6× 310 0.9× 76 3.1k
Donald B. Carter United States 20 969 1.0× 1.2k 2.3× 474 1.1× 488 1.3× 232 0.7× 44 2.3k
Noémi Kedei United States 27 1.2k 1.2× 395 0.8× 330 0.7× 404 1.1× 381 1.1× 73 2.4k
Varghese John United States 23 706 0.7× 651 1.3× 169 0.4× 407 1.1× 146 0.4× 66 1.6k
Simona Daniele Italy 31 1.4k 1.5× 407 0.8× 448 1.0× 246 0.6× 508 1.4× 129 3.0k
Stefan von Berg Sweden 16 666 0.7× 402 0.8× 230 0.5× 257 0.7× 218 0.6× 21 1.3k
Scott J. Pollack United States 22 1.4k 1.5× 630 1.2× 351 0.8× 211 0.6× 323 0.9× 38 2.4k
Matthew Kennedy United States 23 1.1k 1.2× 700 1.4× 524 1.2× 690 1.8× 121 0.3× 54 2.4k
François Mouton‐Liger France 31 987 1.0× 859 1.7× 321 0.7× 190 0.5× 203 0.6× 78 2.3k

Countries citing papers authored by Brian Lockhart

Since Specialization
Citations

This map shows the geographic impact of Brian Lockhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lockhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lockhart more than expected).

Fields of papers citing papers by Brian Lockhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Lockhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lockhart. The network helps show where Brian Lockhart may publish in the future.

Co-authorship network of co-authors of Brian Lockhart

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Lockhart. A scholar is included among the top collaborators of Brian Lockhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Lockhart. Brian Lockhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hurwitz, Stephanie N., Brian Lockhart, Özlem Önder, et al.. (2023). Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker. Modern Pathology. 36(7). 100170–100170. 3 indexed citations
2.
Pierga, Jean‐Yves, Charlotte Proudhon, Michael R. Speicher, et al.. (2020). Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. Cancers. 12(6). 1481–1481. 13 indexed citations
3.
Campone, Mario, Thomas Bachelot, Frédérique Penault‐Llorca, et al.. (2019). A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 83(4). 743–753. 15 indexed citations
4.
Burbridge, Mike F., Céline Bossard, Imre Fejes, et al.. (2013). S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab. Molecular Cancer Therapeutics. 12(9). 1749–1762. 74 indexed citations
5.
Galizzi, Jean‐Pierre, Brian Lockhart, & Antoine Bril. (2013). Applying systems biology in drug discovery and development. Drug metabolism and drug interactions. 28(2). 67–78. 4 indexed citations
6.
Bergé, Mathieu, David Allanic, Philippe Bonnin, et al.. (2011). Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. Journal of Hepatology. 55(4). 866–875. 73 indexed citations
7.
Capel, Frédéric, Michel Lonchampt, Gaëlle Rolland, et al.. (2011). Aging and Obesity Induce Distinct Gene Expression Adaptation in the Liver of C57BL/6J Mice. Lifestyle Genomics. 4(3). 154–164. 6 indexed citations
8.
Dumont, Aurélie, Audrey Sirvent, Michel Jan, et al.. (2011). Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells. PLoS ONE. 6(2). e17237–e17237. 33 indexed citations
9.
Lockhart, Brian, et al.. (2008). Preparation and affinity profile of novel nicotinic ligands. Bioorganic & Medicinal Chemistry Letters. 18(6). 2188–2193. 4 indexed citations
10.
Lockhart, Brian. (2003). Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?. Experimental Gerontology. 38(1-2). 119–128. 31 indexed citations
11.
Lockhart, Brian, et al.. (2001). Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration. European Journal of Pharmacology. 416(1-2). 59–68. 20 indexed citations
12.
13.
Lockhart, Brian, et al.. (2000). A convenient extension of the Wessely–Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro. Bioorganic & Medicinal Chemistry Letters. 10(8). 835–838. 112 indexed citations
14.
15.
Volonté, Cinzia, Maria Teresa Ciotti, Nadia D’Ambrosi, Brian Lockhart, & Michael Spedding. (1999). Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology. 38(9). 1335–1342. 48 indexed citations
16.
Lockhart, Brian, et al.. (1998). Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia. British Journal of Pharmacology. 123(5). 879–889. 34 indexed citations
17.
Maurice, Tangui, Brian Lockhart, & Alain Privat. (1996). Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Research. 706(2). 181–193. 468 indexed citations
18.
Maurice, Tangui, Brian Lockhart, Tsung-Ping Su, & Alain Privat. (1996). Reversion of β25–35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Research. 731(1-2). 249–253. 55 indexed citations
19.
20.
Lockhart, Brian, Thomas P. Smith, & Christopher J. Bailey. (1991). Immunofluorescence localization of the epidermolytic toxin target in mouse epidermal cells and tissue. The Histochemical Journal. 23(9). 385–391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuemang Yao Breakdown of academic impact, for papers by Christophe Furman Breakdown of academic impact, for papers by Donald B. Carter Breakdown of academic impact, for papers by Noémi Kedei Breakdown of academic impact, for papers by Varghese John Breakdown of academic impact, for papers by Simona Daniele Breakdown of academic impact, for papers by Stefan von Berg Breakdown of academic impact, for papers by Scott J. Pollack Breakdown of academic impact, for papers by Matthew Kennedy Breakdown of academic impact, for papers by François Mouton‐Liger
Rankless by CCL
2026